High CD204 expression in TAMs correlates with short overall survival (OS), disease-free survival (DFS) and RFS in colorectal cancer, cervical cancer, breast cancers and oral squamous cell carcinoma (OSCC) (24, 74–76). This evidence concerns the gene MSR1 and cervical carcinoma.